The FDA announced on March 4, 2020, that Diagnostica Stago, Inc. is recalling STA - Deficient VIII due to a risk of sample-to-sample cross-contamination that may cause falsely increased factor VIII levels. The agency issued recall number Z-1699-2020 for the immuno-depleted human plasma product.
How to tell if you have it
- Brand: Stago
- Product: STA - Deficient VIII, Product Code: 00725
- Units affected: 3,225 units
The hazard
The recall addresses a risk of sample-to-sample cross-contamination of Emicizumab for factor VIII assays on Stago instruments. This contamination may cause clotting times to be shortened, which can result in factor VIII levels being reported as falsely increased.
Context
GovInfoNow's records show Diagnostica Stago, Inc. has 12 other recalls on record since 2026-07-29. Other recent recalls of similar products include the Fujirebio Lumipulse pTau 217 Plasma Controls Recall (2025-12-11), the Tosoh ST AIA-Pack Testosterone Recall (2026-06-12), and the Vivoo Protein Test Recall (2025-11-22).